Systemic effects of fluoroscopically guided epidural steroid injection with dexamethasone
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Epidural steroid injections (ESIs) have been widely used in managing spinal pain. Dexa-methasone has recently emerged as a useful drug in this setting, relative to particulate steroids, although the associated systemic effects have not been fully elucidated. This study aimed to investigate the incidences and types of systemic effects after fluoroscopically guided ESI with dexamethasone.Methods: This retrospective study included 888 ESIs with dexamethasone (fluoroscopically guided at the cervical and lumbosacral levels) performed on 825 patients during January to June 2017. Data regarding systemic effects were collected via telephone interviews using a standardized questionnaire at 2 weeks after the procedure. Data on patient demographic, clinical, and procedural characteristics were collected and analyzed to identify factors that were associated with systemic effects. All statistical analyses were performed using the chi-squared test.Results: Among the 825 patients, 40 patients (4.8%) experienced systemic effects during the 2-week follow-up period. The most common systemic effect was facial flushing (12 patients, 1.5%), which was followed by urticaria (7 patients, 0.8%) and insomnia (7 patients, 0.8%). A history of spine surgery was significantly associated with the occurrence of systemic effects (P = 0.036). Systemic effects were significantly more com-mon for injections at the cervical level than at the lumbar level (P = 0.019).Conclusions: Approximately 4.8% of the patients who underwent ESI with dexamethasone experienced minor and transient systemic effects. These effects were more common in patients who had undergone a previous spine surgery or received a cervical ESI.
Abstract
Background: Epidural steroid injections (ESIs) have been widely used in managing spinal pain. Dexa-methasone has recently emerged as a useful drug in this setting, relative to particulate steroids, although the associated systemic effects have not been fully elucidated. This study aimed to investigate the incidences and types of systemic effects after fluoroscopically guided ESI with dexamethasone.Methods: This retrospective study included 888 ESIs with dexamethasone (fluoroscopically guided at the cervical and lumbosacral levels) performed on 825 patients during January to June 2017. Data regarding systemic effects were collected via telephone interviews using a standardized questionnaire at 2 weeks after the procedure. Data on patient demographic, clinical, and procedural characteristics were collected and analyzed to identify factors that were associated with systemic effects. All statistical analyses were performed using the chi-squared test.Results: Among the 825 patients, 40 patients (4.8%) experienced systemic effects during the 2-week follow-up period. The most common systemic effect was facial flushing (12 patients, 1.5%), which was followed by urticaria (7 patients, 0.8%) and insomnia (7 patients, 0.8%). A history of spine surgery was significantly associated with the occurrence of systemic effects (P = 0.036). Systemic effects were significantly more com-mon for injections at the cervical level than at the lumbar level (P = 0.019).Conclusions: Approximately 4.8% of the patients who underwent ESI with dexamethasone experienced minor and transient systemic effects. These effects were more common in patients who had undergone a previous spine surgery or received a cervical ESI.
참고문헌 (31)
- Manchikanti L, "Assessment of the growth of epidural injections in the medicare population from 2000 to 2011", Pain Physician, 16, pp.E349~64 (2013)
- McLain RF, "Epidural steroid therapy for back and leg pain : mechanisms of action and efficacy", Spine J, 5, pp.191~201 (2005)
- Saal JS, "High levels of inflammatory phospholipase A2activity in lumbar disc herniations", Spine (Phila Pa 1976), 15, pp.674~678 (1990)
- Bensler S, "Long term outcomes from CT-guided indirect cervical nerve root blocks and their relationship to the MRI findings--a prospective Study", Eur Radiol, 25, pp.3405~3413 (2015)
- Watts RW, "A meta-analysis on the efficacy of epidural corticosteroids in the treatment of sciatica", Anaesth Intensive Care, 23, pp.564~569 (1995)
- Epstein NE, "The risks of epidural and transforaminal steroid injections in the spine: commentary and a comprehensive review of the literature", Surg Neurol Int, 4(Suppl 2), pp.S74~S93 (2013)
- Botwin KP, "Adverse effects of fluoroscopically guided interlaminar thoracic epidural steroid injections", Am J Phys Med Rehabil, 85, pp.14~23 (2006)
- Botwin KP, "Complications of fluoroscopically guided interlaminar cervical epidural injections", Arch Phys Med Rehabil, 84, pp.627~633 (2003)
- Botwin KP, "Complications of fluoroscopically guided transforaminal lumbar epidural injections", Arch Phys Med Rehabil, 81, pp.1045~1050 (2000)
- Derby R, "Complications following cervical epidural steroid injections by expert interventionalists in 2003", Pain Physician, 7, pp.445~449 (2004)
- Huston CW, "Complications and side effects of cervical and lumbosacral selective nerve root injections", Arch Phys Med Rehabil, 86, pp.277~283 (2005)
- Pobiel RS, "Selective cervical nerve root blockade : prospective study of immediate and longer term complications", AJNR Am J Neuroradiol, 30, pp.507~511 (2009)
- Karaman H, "The complications of transforaminal lumbar epidural steroid injections", Spine (Phila Pa 1976), 36, pp.E819~E824 (2011)
- Plastaras C, "Adverse e vents associated w ith flu oroscopically guided lumbosacral transforaminal epidural steroid injections", Spine J, 15, pp.2157~2165 (2015)
- McGrath JM, "Incidence and characteristics of complications from epidural steroid injections", Pain Med, 12, pp.726~731 (2011)
- Manchikanti L, "A prospective evaluation of complications of 10, 000 fluoroscopically directed epidural injections", Pain Physician, 15, pp.131~140 (2012)
- El Abd O, "Immediate and acute adverse effects following transforaminal epidural steroid injections with dexamethasone", Pain Physician, 18, pp.277~286 (2015)
- Watkins TW, "Ropivacaine and dexamethasone : a potentially dangerous combination for therapeutic pain injections", J Med Imaging Radiat Oncol, 59, pp.571~577 (2015)
- 이근영, "The Incidence of Various Types of Systemic Reactions Related to Epidural Steroid Injections: A Prospective Observational Study", Korean Journal of Radiology, 19(2), pp.301~310 (2018), 대한영상의학회[DOI]
- Palmer WE, "Spinal injections for pain management", Radiology, 281, pp.669~688 (2016)
- MacMahon PJ, "Spine injectables : what is the safest cocktail", Am J Roentgenol, 207, pp.526~533 (2016)
- Schneider B, "Safety of epidural steroid injections", Expert Opin Drug Saf, 15, pp.1031~1039 (2016)
- Goodman BS, "Complications and pitfalls of lumbar interlaminar and transforaminal epidural injections", Curr Rev Musculoskelet Med, 1, pp.212~222 (2008)
- Derby R, "Size and aggregation of corticosteroids used for epidural injections", Pain Med, 9, pp.227~234 (2008)
- MacMahon PJ, "Injectable corticosteroid and local anesthetic preparations : a review for radiologists", Radiology, 252, pp.647~661 (2009)
- Wright JM, "The hydrolysis of cortisol 21-esters by a homogenate of inflamed rabbit synovium and by rheumatoid synovial fluid", Clin Exp Rheumatol, 1, pp.137~141 (1983)
- Dreyfuss P, "Comparative effectiveness of cervical transforaminal injections with particulate and nonparticulate corticosteroid preparations for cervical radicular pain", Pain Med, 7, pp.237~242 (2006)
- Friedly JL, "Systemic effects of epidural steroid injections for spinal stenosis", Pain, 159, pp.876~883 (2018)
- Gala FB, "Imaging in spinal posterior epidural space lesions : a pictorial essay", Indian J Radiol Imaging, 26, pp.299~315 (2016)
- Ahadian FM, "Lumbar transforaminal epidural dexamethasone : a prospective, randomized, doubleblind, dose-response trial", Reg Anesth Pain Med, 36, pp.572~578 (2011)
- Everett CR, "Flu shing as a s ide effect following l umbar t ransforaminal epidural steroid injection", Pain Physician, 7, pp.427~429 (2004)